People: Alere Inc (ALR_pb.N)

ALR_pb.N on New York Stock Exchange

310.14USD
26 Aug 2014
Price Change (% chg)

$-2.12 (-0.68%)
Prev Close
$312.26
Open
$310.14
Day's High
$310.14
Day's Low
$310.14
Volume
30
Avg. Vol
168
52-wk High
$339.80
52-wk Low
$258.22

Search Stocks

Bridgen, John 

Brief Biography

Dr. John Bridgen, Ph.D., is Senior Vice President - Business Development of Alere, Inc. He has served as Senior Vice President, Business Development since July 2010, after serving as our Vice President, Business Development from June 2006 to July 2010. He served as our Vice President, Strategy from September 2005 to June 2006. Dr. Bridgen joined the Company in September 2002, upon our acquisition of Wampole Laboratories, LLC. Dr. Bridgen served as President of Wampole from August 1984 until September 2005. Prior to joining Wampole, Dr. Bridgen had global sales and marketing responsibility for the hematology and immunology business units of Ortho Diagnostic Systems Inc., a Johnson & Johnson company.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
553,600 -- 332,985 886,585

Options Compensation

  Quantity Market Value
Exercisable 56,664 461,362.00
Unexercisable 50,000 149,500.00
Exercised -- --
Name Fiscal Year Total

Namal Nawana

1,307,790

David Teitel

540,779

Daniella Cramp

--

Hilde Eylenbosch

1,071,480

Craig Keyes

--

Sanjay Malkani

--
As Of 30 Dec 2013
Search Stocks